Completed NA INTERVENTIONAL 1-arm NCT04569630

The HEADWIND Study - Part 2 (HEADWIND)

Non-randomised, Controlled, Interventional Single-centre Study for the Design and Evaluation of an In-vehicle Hypoglycaemia Warning System in Diabetes - The HEADWIND Study Part 2

Sponsor: ETH Zurich

Conditions Diabetes Diabetes Mellitus, Type 1

Interventions Controlled hypoglycaemic state while driving

Updated 7 times since 2020 Last updated: Jun 28, 2021 Started: Oct 1, 2020 Primary completion: May 27, 2021 Completion: May 28, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabetes and Diabetes Mellitus, Type 1 and is currently completed. ETH Zurich leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Jul 2023 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2020 — Jan 2021 [monthly]

Recruiting NA
Oct 2020 — Dec 2020 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ETH Zurich
Insel Gruppe AG, University Hospital Bern
University of St.Gallen

Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland